Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study (Q83737517)
Jump to navigation
Jump to search
scientific article published on 22 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study |
scientific article published on 22 March 2012 |
Statements
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study (English)
David S Boyer
Alan F Cruess
Jason S Slakter
Stefan Pilz
Annemarie Weisberger
DENALI Study Group